Astragalus and Moringa Stand As Herbs With Anticancer Properties

Herbal medicine has long been in practice with its roots being evidenced in the paleolithic era since at least 49,000 years ago. With the anti-inflammatory herbs such as yarrow and chamomile being extracted from the hardened plaque that was cased on the teeth of someone who lived in 49,000 BCE, it’s been long established as a practical method to treat ailments and maladies.

Moringa was noted in the Ayurveda texts thousands of years ago and Astragalus was recorded for its medicinal usages in the Shen Nong Bencao Jing which is speculated to have been created in the Han Dynasty and existed from 206 BCE – 220 AD. But it is now in 2025 where an accumulation of studies can provide merit in how astragalus and moringa can act as preventatives for cancer.

Concerning Astragalus, compounds extracted from the root can serve in preventing nutrients and oxygen from reaching lung cancer cells via angiogenesis when used in treatments. Compared to previous treatments without the usage of Astragalus, Astragalus compounds in a recent study provided improvement in vascular structure, a repaired blood composition, an acceleration in the circulatory system, and a prevention in angiogenesis aiding cancer cells. It also promoted vascular normalization, which aids in reducing tumor invasion and the spreading of cancer cells. This ultimately led to a delay in lung cancer growth.

Astragalus compounds derived from the plant not only acted as a preventative for lung cancer growth, but astragalus compounds also prevented the spreading of gastric cancer cells via apoptosis, or cell death. A 2025 study treated gastric cancer cells with different concentrations of the astragalus compound and assessed cell proliferation as well as the occurrence of apoptosis. Results showed consistent treatment provided an occurrence of apoptosis with gastric cancer cells and a prevention in cancer cell spreading. With an evaluated dosage and specified treatment per patient, astragalus compounds can have merit for prevention in gastric cancer cell spreading.

Astragalus compounds were also found to have the same affect of apoptosis and prevention in cancer cell spreading when it came to colorectal cancer. Astragalus compounds also prevented angiogenesis from occurring with colorectal cancer cells as well as a regulation in the cell cycles and a reversing of drug resistance. There was also more efficacy between dosages of astragalus compound when included in treatment for chemotherapy, radiotherapy, targeted therapy, and surgery.

Synergy between astragalus and other components in cancer treatment have begun to show merit when paired with well-known pharmaceutical drugs. Doxorubicin and Cisplatin are drugs used during cancer treatment and both have positive results when incorporated with an intake of astragalus during treatment. For Doxorubicin there is a concern of cardiotoxicity when taking the pharmaceutical drug. Incorporating an intake of astragalus alongside Doxorubicin can reduce oxidative stress and preserve mitochondrial function while overall preventing cardiotoxicity. Taking astragalus with Cisplatin for breast cancer treatment enhanced the effects of Cisplatin by showing higher efficacy in the prevention of the multiplying, spreading, and invasiveness of breast cancer cells.

It might even have promise concerning treatment of leukemogenesis, possibly preventing the continuation of inherited leukemia. In a study with mice, the drug Astragaloside-A which has astragalus compounds was used on leukemia cells to observe if there was a change in cancer cells, apoptosis, or cell spreading. Results showed that Astragaloside-A inhibits leukemogenesis during the early stages and suppresses leukemia which overall shows promise for the multiple benefits astragalus can provide for patients undergoing cancer treatment.

For moringa, not only might it reduce effects of anemia in children, aid in eye health, aid in stomach health, reduce cholesterol levels, improve cardiovascular health, lower blood pressure, reduce inflammation, protect the liver, contain neuroprotective effects, aid the kidneys, and reduce asthmatic symptoms, it might have potential as a preventative for multiple cancers. When compounds of moringa were infused with other compounds to treat liver cancer and breast cancer, results showed cell damage to liver cancer cells and breast cancer cells occurred and that moringa had the highest efficacy of all extracted compounds. Another study combined gold nanoparticles with moringa compounds to study its effects on lung cancer treatment. Results showed cell damage and even apoptosis of lung cancer cells, revealing potential for moringa to grow in this field of treatment.

These are very promising results of moringa and astragalus in the medical field! However, before ingesting these herbal remedies, just note moringa increases iron in the blood which can cause stomach problems and intensify the effects of hemochromatosis. High doses of astragalus should not be taken if you are taking immune-suppressing drugs. Pregnant or nursing women should not take astragalus either. And astragalus should not be taken if you have an autoimmune disease, lupus, multiple sclerosis, or rheumatoid arthritis.

Like with any supplements you may have questions about, please consult with your primary physician. And as always stay well, live well, and thrive on.